Abiopharma

Zoetis Announces Third Quarter 2025 Results

AC Immune Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

EDAP to Present at Jefferies Global Healthcare Conference in London

InspireMD Reports Third Quarter 2025 Financial Results

Tonix Pharmaceuticals Announces Collaboration with Massachusetts General Hospital to Advance Phase 2 Clinical Trial of Dimeric Fc-modified anti-CD40L mAb, TNX-1500, to Prevent Kidney Transplant Organ Rejection

Ocular Therapeutix™ Achieves Target Randomization of 555 Subjects in SOL-R

Compugen to Participate in Stifel 2025 Healthcare Conference

Merck Enters into Research and Development Funding Agreement with Blackstone Life Sciences for Sacituzumab Tirumotecan (sac-TMT)

BD Achieves Milestone in AGILITY Study of Revello™ Vascular Covered Stent for Treatment of Peripheral Artery Disease

Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance